arBtrage CAPITALIZING MARKETS checking… Sign in

Cabaletta Bio, Inc.

CABA Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$3.25
▼ -7.4% Today
as of Jun 7, 06:55 ET
Last 30 days +13.64% Apr 28 → Jun 05
$2.67 $3.07 $3.47 $3.86 $4.26 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$3.48
High
$3.51
Low
$3.21
Volume
$4M
Avg Vol
$3M
Mkt Cap
$615M
P/E (TTM)
Beta
52w High
$4.23
52w Low
$1.26
Div Yield
Shares Out

Overview

52-week range
$1.26
$4.23
67% of range
Avg surprise (last 2)
-0.5%
Avg reaction (last 2)
+19.9%
100% positive
Latest IV / EM
117%
EM ±16.2% · $3 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.73$-0.64$-0.55$-0.46$-0.37 Actual $-0.37Actual $-0.37Actual $-0.51Actual $-0.56Actual $-0.62Actual $-0.71Est $-0.67Actual $-0.73Actual $-0.44Actual $-0.39Est $-0.41 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-45M$-41M$-37M$-33M$-29M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 14, 2026Mar/2026 $-0.39 $-0.41 +4.9% +45.1% +0.6% earnings
Tue Sep 30, 2025Sep 2025 $-0.44 financials
Mon Jun 30, 2025Jun 2025 $-0.73 financials
Thu May 15, 2025Mar/2025 $-0.71 $-0.67 -6.0% +39.2% earnings
Mon Sep 30, 2024Sep 2024 $-0.62 financials
Sun Jun 30, 2024Jun 2024 $-0.56 financials
Sun Mar 31, 2024Mar 2024 $-0.51 financials
Sat Sep 30, 2023Sep 2023 $-0.37 financials
Fri Jun 30, 2023Jun 2023 $-0.37 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-44M$-47M$-46M$-37M$-33M$-30M
Net income$-44M$-45M$-45M$-36M$-31M$-28M
EPS (diluted)$-0.39$-0.44$-0.73$-0.71$-0.62$-0.56

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$117M$83M$60M$146M$132M$164M$171M$179M
Inventory
Total current assets$122M$139M$165M$198M$135M$167M$186M$206M
Total assets$148M$165M$190M$224M$165M$185M$204M$217M
Long-term debt
Total liabilities$45M$53M$50M$46M$44M$33M$30M$18M
Total equity$103M$112M$139M$178M$122M$152M$174M$200M

Implied volatility — last 90 days

111%114%116%119%121% Jun 07 — IV 117% · EM ±16.2%

Sector peers